(Q48514891)

English

Selective serotonin reuptake inhibitors, fluoxetine and paroxetine, attenuate the expression of the established behavioral sensitization induced by methamphetamine

scientific article

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/16738540

Selective serotonin reuptake inhibitors, fluoxetine and paroxetine, attenuate the expression of the established behavioral sensitization induced by methamphetamine (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/16738540

0 references

1 reference

based on heuristic

inferred from title

author name string

Yujiro Kaneko

1

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/16738540

Atsushi Kashiwa

2

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/16738540

Takashi Ito

3

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/16738540

Sumikazu Ishii

4

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/16738540

Asami Umino

5

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/16738540

Toru Nishikawa

6

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/16738540

language of work or name

0 references

publication date

31 May 2006

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/16738540

Neuropsychopharmacology

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/16738540

32

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/16738540

3

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/16738540

658-664

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/16738540

The 5-HT1A receptor modulates the effects of cocaine on extracellular serotonin and dopamine levels in the nucleus accumbens

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301111

21 January 2018

Interchangeability of stress and amphetamine in sensitization

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301111

21 January 2018

5-HT2A and alpha1b-adrenergic receptors entirely mediate dopamine release, locomotor response and behavioural sensitization to opiates and psychostimulants

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301111

21 January 2018

Amphetamine-induced locomotor activation in 5-HT(1B) knockout mice: effects of injection route on acute and sensitized responses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301111

21 January 2018

Intravenous cocaine self-administration in rats is reduced by dietary L-tryptophan

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301111

21 January 2018

5-HT2 receptor antagonists given in the acute withdrawal from daily cocaine injections can reverse established sensitization

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301111

21 January 2018

Regionally and functionally distinct serotonin3 receptors control in vivo dopamine outflow in the rat nucleus accumbens

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301111

21 January 2018

Regulation of adult neurogenesis by antidepressant treatment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301111

21 January 2018

Evolving behavior in the clinical and experimental amphetamine (model) psychosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301111

21 January 2018

Serotonin-dopamine interaction as a focus of novel antidepressant drugs

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301111

21 January 2018

Effects of selective serotonin and serotonin/noradrenaline reuptake inhibitors on extracellular serotonin in rat diencephalon and frontal cortex

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301111

21 January 2018

Influence of fluoxetine and paroxetine in behavioral sensitization induced by ethanol in mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301111

21 January 2018

Genetic ablation of orexin neurons in mice results in narcolepsy, hypophagia, and obesity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301111

21 January 2018

Pharmacokinetics of selective serotonin reuptake inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301111

21 January 2018

Blockade of the expression of sensitization and tolerance by ondansetron, a 5-HT3 receptor antagonist, administered during withdrawal from intermittent and continuous cocaine.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301111

21 January 2018

Long-term blockade of the expression of cocaine sensitization by ondansetron, a 5-HT(3) receptor antagonist.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301111

21 January 2018

Chronic olanzapine or fluoxetine administration increases cell proliferation in hippocampus and prefrontal cortex of adult rat.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301111

21 January 2018

A single cocaine exposure increases BDNF and D3 receptor expression: implications for drug-conditioning.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301111

21 January 2018

Pharmacological reversal of behavioral and cellular indices of cocaine sensitization in the rat.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301111

21 January 2018

Cell proliferation in adult hippocampus is decreased by inescapable stress: reversal by fluoxetine treatment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301111

21 January 2018

Brain-derived neurotrophic factor expression is increased in the rat amygdala, piriform cortex and hypothalamus following repeated amphetamine administration

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301111

21 January 2018

Fluoxetine pretreatment reduces breaking points on a progressive ratio schedule reinforced by intravenous cocaine self-administration in the rat.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301111

21 January 2018

Increased vulnerability to cocaine in mice lacking the serotonin-1B receptor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301111

21 January 2018

Subchronic fluoxetine treatment induces a transient potentiation of amphetamine-induced hyperlocomotion: possible pharmacokinetic interaction.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301111

21 January 2018

Augmentation with fluvoxamine but not maprotiline improves negative symptoms in treated schizophrenia: evidence for a specific serotonergic effect from a double-blind study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301111

21 January 2018

Selective serotonin re-uptake inhibitor augmentation in the treatment of negative symptoms of schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301111

21 January 2018

Amphetamine psychosis: a "model" schizophrenia mediated by catecholamines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301111

21 January 2018

Serotonin and brain development.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301111

21 January 2018

A serotonin 5-HT1A receptor agonist prevents behavioral sensitization to L-DOPA in a rodent model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301111

21 January 2018

Clinical features of sensitization to methamphetamine observed in patients with methamphetamine dependence and psychosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301111

21 January 2018

Alterations in dopaminergic and glutamatergic transmission in the induction and expression of behavioral sensitization: a critical review of preclinical studies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301111

21 January 2018

Repetitive cocaine administration decreases neurogenesis in adult rat hippocampus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301111

21 January 2018

Activation of 5-HT(1B/1D) receptors in the mesolimbic dopamine system increases dopamine release from the nucleus accumbens: a microdialysis study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301111

21 January 2018

Involvement of 5-HT1B receptors within the ventral tegmental area in regulation of mesolimbic dopaminergic neuronal activity via GABA mechanisms: a study with dual-probe microdialysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301111

21 January 2018

Time-dependent increases in brain-derived neurotrophic factor protein levels within the mesolimbic dopamine system after withdrawal from cocaine: implications for incubation of cocaine craving.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301111

7 January 2021

based on heuristic

inferred from DOI database lookup

Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301111

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of intracerebroventricular administration of pituitary adenylate cyclase-activating polypeptide (PACAP) on the motor activity and reserpine-induced hypothermia in murines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301111

7 January 2021

based on heuristic

inferred from DOI database lookup

Behavioral sensitization and relative hyperresponsiveness of striatal and limbic dopaminergic neurons after repeated methamphetamine treatment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301111

7 January 2021

based on heuristic

inferred from DOI database lookup

Fluvoxamine treatment of obsessive-compulsive symptoms in schizophrenic patients: an add-on open study.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301111

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.NPP.1301111

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/16738540

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/16738540

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48514891&oldid=2209549431"